Business Standard

Tuesday, January 07, 2025 | 09:55 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Dr Reddy's extends gain ; up 9% in one week

The company on Monday, December 11, announced that it has received EIR from the US drug regulator for its facility in Bachupally, Hyderabad following the audit in April

reddy, dr reddy's
Premium

Dr Reddy's laboratory

SI Reporter Mumbai
Dr Reddy’s Laboratories moved higher by 3% to Rs 2,380, gaining 9% during the week. The pharmaceutical company is the top weekly gainer among the S&P BSE Sensex stocks.

The company on Monday, December 11, 2017 announced that it has received Establishment Inspection Report (EIR) from the US drug regulator for its facility in Bachupally, Hyderabad following the audit in April. 

“We have received EIR from the US Food and Drug Administration (USFDA) on December 11, 2017 as closure of audit, for formulations manufacturing plant-3 at Bachupally, Hyderabad,” Dr Reddy’s Laboratories said in a statement.

The above-referred

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in